New developments in cervical cancer screening and prevention


New developments in cervical cancer screening and prevention

edited by Eduardo Franco and Joseph Monsonego ; foreword by Albert Singer

Blackwell Science, 1997


Singer, Albert

大学図書館所蔵 件 / 3



Papers based on a three day workshop held June 17-19, 1996, in Geneva, Switzerland

Includes bibliographical references and index



EUROGIN (European Research Organistation on Genital Infection and Neoplasia) brings together clinicians and scientists who work on genital infections and their relationship to cancer. The aim is to promote and develop research, training, screening, prevention and information on genital infections, precancers and cancers in women. This book reviews the latest developments in the epidemiology, natural history and screening of cervical cancer. It also deals with management of cervical cancer, the development of vaccines against human papilloma virus - its major


  • Section 1: Epidemiology and Public Health Aspects of Cervical Cancer:
  • Human Papillomavirus and Cervical Cancer: Epidemiological Evidence
  • Epidemiology of Cervical Human Papillomavirus Infection
  • Geographical and Social Patterns of Cervical Cancer Incidence
  • The Male Role in Cervical Carcinogenesis: Lessons from the Studies in Colombia and Spain and a Challenge for the Future
  • Statistical Issues in Studies of Human Papillomavirus Infection and Cervical Cancer
  • The Epidemiological Basis for Evaluating Screening Policies
  • Prevention Measures in the Third World: Are they Practical?
  • Prevention of Sexually Transmitted Infections through Health Education and Counselling: A General Framework
  • Section 2: Natural History and Management of Cervical Cancer Precursors: Biological Behaviour of Cervical Intraepithelial Neoplasia
  • Optimal Management of Cervical Cancer Precursors: Low Grade Squamous Intraepithelial Lesions
  • Optimal Management of Cervical Cancer Precursors: High-Grade Lesions
  • Glandular Lesions: An Increasing Problem
  • Papillomavirus Infection and Neoplasia in Women Infected with Human Immunodeficiency Virus
  • Section 3: The Cervical Cytology Paradigm: Performance of Cytology in Screening for Precursor Lesions and Early Cancer of the Uterine Cervix
  • The Bethesda System (TBS): Advantages and Pitfalls
  • Quality Assurance in Cervical Cytopathology
  • Error Rates in Cervical Cancer Screening: Causes and Consequences
  • Cervical Cancer Following Negative Smears
  • Section 4: Cytology Screening Programmes: Organization, Monitoring and Use of Resources for Screening Programmes
  • Cervical Screening by General Practitioners and Nurses and Information Feedback Systems
  • Screening Programmes: Results and Expectations
  • Screening for Cervical Cancer: Experience of the Nordic Countries
  • Screening that Failed to Work
  • Implementation and Evaluation of Cervical Cancer Screening Programmes in the European Union
  • Organization and results of Cervical Cancer Screening in Europe Over the Past 20 Years
  • Spontaneous Screening: Benefits and Limitations
  • Is Cervical Cancer Cytological Screening Valuable in Developing Countries?
  • Screening in Cervical Cancer Prevention in Porto Alegre, Brazil: The Experience of a Programme in a Developing Country
  • Section 5: Automation in Cytology: Automation and Cervical Cytopathology: An Overview
  • Automation in Cervicovaginal Cytology: System Requirements and Benefits
  • Automated Screening using the AutoPap 300 Device
  • Liquid-based Cytology: Comparison of ThinPrep 2000 with Conventionally Prepared Pap Smears
  • The History of Neural Network Technology in Cytology
  • A Comparison of Automated and Manual Screening: Theoretical Considerations
  • Cooperation of the Image Analyser and the Cytologist
  • Advantages and Limitations of Automated Screening Systems in Developing and Developed Countries
  • Section 6: Human Papillomavirus Testing: Methods of DNA Hybridization and their Clinical Applicability to Human Papillomavirus Detection
  • Human Papillomavirus Testing for Primary Cervical Cancer Screening
  • Human Papillomavirus DNA Testing Using Liquid-based Cytology
  • Human Papillomavirus Testing for Diagnostic Triage of Minor-grade Cytological Abnormalities: The European Perspective
  • Use of Human Papillomavirus Tying for Quality Assurance of Cytological Diagnosis
  • Estimates of the Cost Impact of Introducing Human Papillomavirus Testing into a Cervical Screening Programme
  • Viral Load as a Surrogate for Persistence in Cervical Human Papillomavirus Infection
  • Molecular Variant Analysis as a Tool in Natural History Studies of Human Papillomavirus Infection and Cervical Neoplasia
  • Section 7: Adjunct Screening Tests: Evaluation of Multiple Screening Techniques in a High-risk Area: The Guanacaste Project
  • Colposcopy as a Screening Tool for Cervical Cancer Detection: A Review
  • Adjuvant Tests to Cytology: Cervicography and the Polarprobe
  • Visual Inspection as a Screening Test for Cervical Cancer Control in Developing Countries
  • Section 8: Prevention and Therapy by Immunization: Human Papillomavirus Vaccines and Their Potential use in the Prevention and Treatment of Cervical Neoplasia
  • Animal Models for Evaluation of Human Papillomavirus Vaccines
  • Induction of Human Papillomavirus-Specific Immune Response
  • Section 9: Summary of Presentations and Consensus: Rapporteurs' Summary and Presentations
  • Highlights and Consensus
  • Index

「Nielsen BookData」 より